SEARCH HEALTH CONDITIONS BY ALPHABETS
Autoimmune Neutropenia
Medications for Autoimmune Neutropenia
Other names: Neutropenia, Auto-immune
Concerning Autoimmune Neutropenia: Autoimmune Neutropenia could be the presence of small variety of neutrophils in the circulating blood, due to an autoimmune condition where the body destroys neutrophils faster than they can be produced.
Drugs Used to Treat Autoimmune Neutropenia
The following set of medications are somehow related to, or found at the treating this illness.
| Drug name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| immune globulin intravenousAway Tag | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: immune globulin intravenous systemic Drug class: resistant globulins For consumers: dose, interactions, Off Label: Yes | |||||||
Legend
| Rx | prescription-only |
|---|---|
| OTC | Over the Counter |
| Rx/OTC | Prescription or Over the Counter |
| Away Tag | This drug might well not be accepted by the FDA for the treatment of the illness. |
| Pregnancy Category | |
|---|---|
| A | Adequate and well-controlled studies have failed to present a risk to the embryo within the first trimester of pregnancy (also there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
| C | Animal reproduction studies have demonstrated an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but possible benefits may warrant use in pregnant women despite potential risks. |
| D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but possible benefits may justify use in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. |
| N | FDA has not classified the medication. |
| Controlled Substances Act (CSA) Schedule | |
|---|---|
| N | Is not subject to the Controlled Substances Act. |
| 1 | features a higher potential for abuse. Has no accepted medical use in treatment in the USA. There is a lack of accepted safety for use under medical supervision. |
| Two | features a higher potential for abuse. Features a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the USA. Abuse may result in acute physical or emotional dependency. |
| 3 | includes a potential for abuse less than individuals in programs 1 and 2 2. Features a currently accepted medical use in treatment in the USA. Abuse may lead to physical dependence or high psychological dependence. |
| 4 | features a low potential for abuse relative to individuals in program 3. It has a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence relative to individuals in program 3. |
| 5 | features a low potential for abuse relative to individuals in program 4. Features a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence relative to individuals in program 4. |
| Infection | |
|---|---|
| X | Interacts with Medication. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- that I
- J
- K
- L
- M
- N
- O
- P
- Q
- Runciman
- S
- T
- U
- V
- W
- X
- Y
- Z
Further information
Always consult your physician to make sure the information displayed on these pages pertains to your circumstances.
Top USA Pharma Companies
Product Categories
Popular Categories
Health Condition
Easily find an affordable health insurance plan
